Biogened S.A. (WSE:BGD)
Poland flag Poland · Delayed Price · Currency is PLN
20.80
0.00 (0.00%)
At close: Jul 24, 2026

Biogened Income Statement

Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
114.04110.9395.5679.6265.32
Revenue Growth (YoY)
2.80%16.09%20.02%21.89%35.15%
Cost of Revenue
4134.2832.0722.1823
Gross Profit
73.0476.6563.4957.4442.32
Selling, General & Admin
63.766.8854.6241.8635.29
Other Operating Expenses
-0.190.4-0.187.173.16
Total Operating Expenses
63.5167.2854.4549.0338.45
Operating Income
9.539.389.048.413.87
Interest Income
000.0100.5
Interest Expense
-2.21-2.37-2.16-1.7-0.6
Other Non-Operating Income (Expense)
-0.43-0.170-0.32-0.16
Total Non-Operating Income (Expense)
-2.63-2.54-2.15-2.02-0.26
Pretax Income
6.96.846.896.393.61
Provision for Income Taxes
2.281.871.793.012.37
Net Income
4.624.975.13.381.24
Minority Interest in Earnings
0-0.8500-0.72
Net Income to Common
4.625.825.13.381.96
Net Income Growth
-20.59%14.22%50.74%72.46%57.92%
Shares Outstanding (Basic)
22222
Shares Outstanding (Diluted)
22222
Shares Change (YoY)
-----
EPS (Basic)
1.882.372.081.380.80
EPS (Diluted)
1.882.372.081.380.80
EPS Growth
-20.59%14.22%50.74%72.46%57.92%
Free Cash Flow
5.13-1.497.72-3.351.57
Free Cash Flow Growth
-----77.12%
Free Cash Flow Per Share
2.09-0.613.14-1.360.64
Dividends Per Share
-0.5000.5000.400-
Dividend Growth
-0%25.00%100.00%-
Gross Margin
64.05%69.10%66.44%72.14%64.78%
Operating Margin
8.36%8.45%9.46%10.56%5.92%
Profit Margin
4.05%4.48%5.33%4.25%1.90%
FCF Margin
4.49%-1.35%8.08%-4.21%2.41%
EBITDA
13.9113.5112.5611.356.75
EBITDA Margin
12.19%12.18%13.14%14.25%10.33%
EBIT
9.539.389.048.413.87
EBIT Margin
8.36%8.45%9.46%10.56%5.92%
Effective Tax Rate
33.00%27.36%26.01%47.09%65.66%